©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessKearns-Sayre syndrome, differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for Kearns-Sayre syndrome containing 3 guideline-curated core genes, 10 additional guideline-curated genes and altogether 18 curated genes according to the clinical signs

ID
KP9877
Number of genes
16 Accredited laboratory test
Examined sequence length
19,6 kb (Core-/Core-canditate-Genes)
30,1 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
  • EDTA-anticoagulated blood (3-5 ml)
  • Gewebeprobe
Diagnostic indications

NGS +

[Sanger]

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
DGUOK834NM_080916.3AR
DNA23183NM_001080449.3AD
MGME11035NM_052865.4AR
OPA12883NM_015560.3AD, AR
POLG3720NM_002693.3AR
POLG21458NM_007215.4AD, AR
RRM2B1272NM_015713.5AR
SPG72388NM_003119.4AR, AD
TK2705NM_001172643.1AR
TWNK2055NM_021830.5AD, AR
AFG3L22394NM_006796.3AD, AR
DMPK1920NM_001081563.2AD
RNASEH1869NM_002936.6AR
SLC25A4897NM_001151.4AD, AR
TOP3A3006NM_004618.5AR
TYMP1449NM_001953.5AR

Informations about the disease

Clinical Comment

Almost always sporadic, >80% of patient have singular mtDNA deletions, more rarely duplications, frequently a 4977 bp deletion (typical localisation, common deletion)

 

Synonyms
  • Alias: CPEO with myopathy
  • Alias: CPEO with ragged-red fibers
  • Alias: Chronic Progressive External Ophthalmoplegia with myopathy
  • Alias: Mitochondrial cytopathy
  • Alias: Oculocraniosomatic syndrome
  • Alias: Ophthalmoplegia, pigmentary degeneration of retina + cardiomyopathy
  • Alias: Ophthalmoplegia, progressive external, with ragged-red fibers
  • Alias: Ophthalmoplegia-plus syndrome
  • Allelic: Perrault syndrome 5 (TWNK)
  • Mitochondrial DNA depletion syndrome 1, MNGIE type (TYMP)
  • Mitochondrial DNA depletion syndrome 11 (MGME1)
  • Mitochondrial DNA depletion syndrome 16 [hepatic type] (POLG2)
  • Mitochondrial DNA depletion syndrome 3 [hepatocerebral type] (DGUOK)
  • Mitochondrial DNA depletion syndrome 4A [Alpers type] (POLG)
  • Mitochondrial DNA depletion syndrome 4B [MNGIE type] (POLG)
  • Mitochondrial DNA depletion syndrome 7 [hepatocerebral type] (TWNK)
  • Mitochondrial DNA depletion syndrome 8A [encephalomyopathic type with renal tubulopathy] (RRM2B)
  • Mitochondrial DNA depletion syndrome 8B [MNGIE type] (RRM2B)
  • Mitochondrial recessive ataxia syndrome [includes SANDO + SCAE] (POLG)
  • Myotonic dystrophy 1 (DMPK)
  • Oculopharyngeal muscular dystrophy (PABPN1)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 3 (TWNK)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 2 (RNASEH1)
  • Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 4 (DGUOK, POLG2)
  • Progressive external ophthalmoplegia, AD 1 (POLG)
  • Progressive external ophthalmoplegia, AR 1 (POLG)
  • Proximal myopathy + ophthalmoplegia (MYH2)
  • Spastic paraplegia 7, AR (SPG7)
Heredity, heredity patterns etc.
  • AD
  • AR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined